Worcester, University of Massachusetts, MA, USA - 25 Sep `20Study to Evaluate RECELL and MKTP for Repigmentation of Stable Vitiligo Lesions

 

Official Title: Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions

In Brief: Prospective randomized within-subject controlled feasibility study to evaluate the clinical performance of RECELL for repigmentation of stable, depigmented lesions. The trial will evaluate 50 matched, stable depigmented areas from 10 subjects.

Ages Eligible: 22 Years and older 

Start Date: September 25, 2020

Completion Date (estimated): December 2021

Status: Recruiting

Study ID from ClinicalTrials.gov: NCT04271501
Other Study ID Numbers: CTP008

Locations: 

  • Worcester, University of Massachusetts, MA, USA. Contact: Celia Hartigan at Celia.Hartigan@umassmed.edu    

Contact: To learn more about this study, you or your doctor may contact 

Elizabeth Kirshner
6613676869
ekirshner@avitamedical.com
 
Lisa Carothers
6614814663
lcarothers@avitamedical.com

Please refer to this study by its NCT number.

FAQOther Questions

  • Is there a special diet for vitiligo?

    In short, no.  Some people find that certain foods may worsen their vitiligo symptoms or that others may improve their skin condition. We found no scientific evidence that a sp...

  • Who is prone to vitiligo?

    Scientists know that some people are genetically predisposed to a specific group of autoimmune diseases – including generalized vitiligo – but do not know who and why.It doesn’t...

  • What tests should be done?

    A well-trained dermatologist should be able to diagnose vitiligo and distinguish it from contact leukoderma or more than twenty other conditions with similar skin appearance bas...